We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > hypercholesterolemia

News List

Public Policy Recs Updated for Familial Hypercholesterolemia drugs
January 06, 2020
In a special communication article, published online Jan. 2 in JAMA Cardiology, updated recommendations are presented for reducing the clinical and public health burden of familial hypercholesterolemia (FH).
More Aggressive Tx Needed for Familial Hypercholesterolemia drugs
September 24, 2019
Even with care in specialty clinics, low-density lipoprotein cholesterol (LDL-C) persists above target levels in more than half of patients with familial hypercholesterolemia (FH) ...
Evinacumab Gets FDA Breakthrough Therapy Designation for Homozygous Familial Hypercholesterolemia americanpharmaceuticalreview
April 07, 2017
Regeneron Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation...